IRCT20190804044429N8
Lacosamide efficasy and safety on pain in patients with multiple sclerosis: A randomized double_blind clinical trial
Mazandaran University of Medical Sciences·Phase 3·Iranian Registry Of Clinical TrialRecruiting
Study focus
- Disease/Condition
- Multiple sclerosis
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Mazandaran University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Sep 23, 2022
- End date
- N/A
ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20190804044429N8
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20190804044429N8 through Pure Global AI's free database. This Phase 3 trial is sponsored by Mazandaran University of Medical Sciences and is currently Recruiting. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.